These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26881710)

  • 1. The Importance of Bioactivation in Computer-Guided Drug Repositioning. Why the Parent Drug is Not Always Enough.
    Talevi A
    Curr Top Med Chem; 2016; 16(19):2078-87. PubMed ID: 26881710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery.
    Prakash C; Sharma R; Gleave M; Nedderman A
    Curr Drug Metab; 2008 Nov; 9(9):952-64. PubMed ID: 18991592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ksRepo: a generalized platform for computational drug repositioning.
    Brown AS; Kong SW; Kohane IS; Patel CJ
    BMC Bioinformatics; 2016 Feb; 17():78. PubMed ID: 26860211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Drug Repositioning Approaches and Resources.
    Xue H; Li J; Xie H; Wang Y
    Int J Biol Sci; 2018; 14(10):1232-1244. PubMed ID: 30123072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network-based inference methods for drug repositioning.
    Chen H; Zhang H; Zhang Z; Cao Y; Tang W
    Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.
    Su EW
    Methods Mol Biol; 2019; 1903():61-72. PubMed ID: 30547436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early estimation of circulating drug metabolites in humans.
    Luffer-Atlas D
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):985-97. PubMed ID: 22681256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
    Re M; Valentini G
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug screening: Drug repositioning needs a rethink.
    Ding X
    Nature; 2016 Jul; 535(7612):355. PubMed ID: 27443733
    [No Abstract]   [Full Text] [Related]  

  • 16. Analytical strategies for the screening and evaluation of chemically reactive drug metabolites.
    Wen B; Fitch WL
    Expert Opin Drug Metab Toxicol; 2009 Jan; 5(1):39-55. PubMed ID: 19236228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging Big Data to Transform Drug Discovery.
    Glicksberg BS; Li L; Chen R; Dudley J; Chen B
    Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of validation strategies for computational drug repositioning.
    Brown AS; Patel CJ
    Brief Bioinform; 2018 Jan; 19(1):174-177. PubMed ID: 27881429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.